Myriad Genetics Inc
MYGN Real Time Price USDRecent trades of MYGN by members of U.S. Congress
---
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in MYGN holdings by institutional investors
Quarterly net insider trading by MYGN's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$40,000 Jul 20, 2026 Issue: Medicare/Medicaid
-
$30,000 Jul 19, 2026 Issue: Medicare/Medicaid
-
$40,000 Jul 18, 2026 Issue: Medicare/Medicaid
-
$30,000 Jul 17, 2026 Issue: Health Issues Medicare/Medicaid
-
$10,000 Jul 03, 2026 Issue: Veterans
-
$260,000 Apr 20, 2026 Issue: Medicare/Medicaid
-
$250,000 Jan 20, 2026 Issue: Medicare/Medicaid
-
$250,000 Oct 20, 2025 Issue: Medicare/Medicaid
-
$290,000 Jul 21, 2025 Issue: Medicare/Medicaid
-
$290,000 Apr 18, 2025 Issue: Medicare/Medicaid Insurance
-
$290,000 Jan 17, 2025 Issue: Medicare/Medicaid
-
$290,000 Oct 17, 2024 Issue: Medicare/Medicaid
-
$290,000 Jul 19, 2024 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$290,000 Jan 22, 2024 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$210,000 Oct 19, 2023 Issue: Medicare/Medicaid Budget/Appropriations
-
$210,000 Jul 17, 2023 Issue: Health Issues Medicare/Medicaid Budget/Appropriations
-
$290,000 Jan 20, 2023 Issue: Health Issues Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$210,000 Oct 19, 2022 Issue: Health Issues Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$180,000 Jul 20, 2022 Issue: Health Issues Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$290,000 Apr 20, 2022 Issue: Health Issues Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$200,000 Jan 20, 2022 Issue: None
-
$160,000 Oct 20, 2021 Issue: None
-
$170,000 Jul 20, 2021 Issue: None
-
$240,000 Apr 20, 2021 Issue: None
-
$210,000 Jan 20, 2021 Issue: None
-
$156,000 Oct 20, 2020 Issue: None
-
$130,000 Jul 20, 2020 Issue: None
-
$220,000 Apr 20, 2020 Issue: None
-
$240,000 Jan 21, 2020 Issue: None
-
$260,000 Oct 21, 2019 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues Budget/Appropriations
-
$170,000 Jul 22, 2019 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Copyright/Patent/Trademark Health Issues Medicare/Medicaid
-
$240,000 Apr 22, 2019 Issue: Medical/Disease Research/Clinical Labs Copyright/Patent/Trademark Medicare/Medicaid
-
$230,000 Jan 22, 2019 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs Copyright/Patent/Trademark
-
$60,000 Oct 18, 2018 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Veterans
Former government officials who have lobbied for MYGN
20 former government officials from 12 congressional offices at 7 lobbying firms have lobbied for MYGN, most recently Jul 21, 2026.
-
Daniel Todd Senate Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Amin Ctr. Medicare & Medicaid
-
Nicholas Uehlecke House Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legislative Assistant, House Ways and Means Subcommittee
-
Eric Bergren House Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker -
Katherine Cotton House Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie
-
Paul Edattel House Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg -
James Hall Senate Staff Director, Senate Veterans Affairs Committee; Legislative Director, Senator Bob Graham
-
Ted Lehman Senate Chief of Staff, Senator Tillis; Senate Judiciary Committee-Counsel, then Chief Counsel for Nominations and Senior Counsel; Senate Judiciary Committee-Staff Assistant and Legislative Assistant -
Taylor Sexton House Advisor to the Assistant Secretary for Preparedness & Response, HHS; Advisor to the Assistant Secretary of Legislation, HHS; Health Care Policy Fellow, Representative Michael Burgess
MYGN Estimated quarterly lobbying spending
MYGN Revenue by Segment or Geography
New MYGN patent grants
-
Patent Title: Artificial intelligence predictive interactivity based on recursive data analysis Jul. 21, 2026
-
Patent Title: Cancer biomarkers Jul. 14, 2026
-
Patent Title: Methods and materials for assessing loss of heterozygosity Jul. 07, 2026
-
Patent Title: Detecting cancer risk May. 26, 2026
-
Patent Title: Methods and materials for assessing loss of heterozygosity Apr. 07, 2026
-
Patent Title: Detecting cancer risk Mar. 17, 2026
-
Patent Title: Methods and materials for assessing homologous recombination deficiency Sep. 23, 2025
-
Patent Title: Hereditary cancer genes Sep. 09, 2025
-
Patent Title: Methods and materials for assessing homologous recombination deficiency Feb. 11, 2025
-
Patent Title: Method of using biomarkers and clinical variables for predicting chemotherapy benefit Nov. 22, 2022
-
Patent Title: Copy number variant caller Jan. 25, 2022
-
Patent Title: Methods and materials for assessing allelic imbalance Jan. 18, 2022
-
Patent Title: Method of treating cancer Nov. 16, 2021
-
Patent Title: Gene signatures for cancer prognosis Nov. 16, 2021
-
Patent Title: Hereditary cancer genes Aug. 31, 2021
-
Patent Title: Genes and gene signatures for diagnosis and treatment of melanoma Jun. 01, 2021
-
Patent Title: Gene signatures for cancer prognosis Mar. 23, 2021
-
Patent Title: Gene signatures for cancer prognosis Dec. 29, 2020
-
Patent Title: Method for treating cancer Dec. 01, 2020
-
Patent Title: Cancer biomarkers Dec. 31, 2019
-
Patent Title: Cancer biomarkers Dec. 10, 2019
-
Patent Title: Methods and materials for assessing homologous recombination deficiency Sep. 03, 2019
-
Patent Title: Cancer biomarkers May. 22, 2018
-
Patent Title: Screening methods and sequences relating thereto Apr. 18, 2017
-
Patent Title: Gene signatures for cancer diagnosis and prognosis Mar. 28, 2017
-
Patent Title: Methods and materials for assessing allelic imbalance Feb. 21, 2017
-
Patent Title: Form Aug. 23, 2016
-
Patent Title: Form Aug. 23, 2016
-
Patent Title: Form Aug. 23, 2016
-
Patent Title: Methods and materials for assessing loss of heterozygosity Jul. 12, 2016
-
Patent Title: Methods and materials for assessing allelic imbalance Mar. 08, 2016
-
Patent Title: Method of assaying 5-fu May. 14, 2013
-
Patent Title: Brca2 mutations and use thereof Aug. 09, 2011
-
Patent Title: Depression-related gene Sep. 14, 2010
-
Patent Title: Myh gene variants and use thereof Mar. 02, 2010
-
Patent Title: Gene copy number profiling Feb. 16, 2010
Federal grants, loans, and purchases
Estimated quarterly amount awarded to MYGN from public contracts
Recent insights relating to MYGN
Recent picks made for MYGN stock on CNBC
ETFs with the largest estimated holdings in MYGN
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $MYGN stock a Buy, Sell, or Hold?
- What is the price target for $MYGN stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $MYGN stock?
- Who owns the most shares of $MYGN stock?
- What funds own $MYGN stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view MYGN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
- Address Salt Lake City, UT
- Market Cap 384.5 million
- Employees 2,700
- Industrial Classification In Vitro & In Vivo Diagnostic Substances
Myriad Genetics Inc (MYGN) Historical Stock Prices
Myriad Genetics Inc (MYGN) closed at $4.02 on September 22, 2026. Over the past year its adjusted close ranged from $2.86 to $8.18. Daily prices go back to January 2, 2014, 3,199 trading days in all.
- 1 month+25.62%
- 3 months-13.17%
- Year to date-34.63%
- 1 year-48.72%
- 3 years-75.80%
- 5 years-88.43%
- Max-81.49%
Quiver Premium charts MYGN's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.
Upgrade to Premium| Date | Open | High | Low | Close | Adj. Close | Volume |
|---|---|---|---|---|---|---|
| Sep 22, 2026 | 3.90 | 4.05 | 3.76 | 4.02 | 4.02 | 2,486,954 |
| Sep 21, 2026 | 3.93 | 4.04 | 3.87 | 4.01 | 4.01 | 1,890,089 |
| Sep 18, 2026 | 4.15 | 4.17 | 3.86 | 3.89 | 3.89 | 3,509,964 |
| Sep 17, 2026 | 3.88 | 4.17 | 3.75 | 4.14 | 4.14 | 2,830,839 |
| Sep 16, 2026 | 3.75 | 4.08 | 3.75 | 3.86 | 3.86 | 2,049,663 |
| Sep 15, 2026 | 3.79 | 3.98 | 3.69 | 3.88 | 3.88 | 4,680,388 |
| Sep 14, 2026 | 3.43 | 3.82 | 3.42 | 3.79 | 3.79 | 2,599,405 |
| Sep 11, 2026 | 3.37 | 3.42 | 3.19 | 3.42 | 3.42 | 2,552,959 |
| Sep 10, 2026 | 3.14 | 3.37 | 3.06 | 3.36 | 3.36 | 3,939,770 |
| Sep 9, 2026 | 3.11 | 3.21 | 3.08 | 3.19 | 3.19 | 966,999 |
| Sep 8, 2026 | 3.18 | 3.21 | 3.10 | 3.18 | 3.18 | 1,194,567 |
| Sep 4, 2026 | 3.19 | 3.20 | 3.15 | 3.19 | 3.19 | 806,164 |
| Sep 3, 2026 | 3.25 | 3.32 | 3.16 | 3.23 | 3.23 | 959,058 |
| Sep 2, 2026 | 3.16 | 3.35 | 3.16 | 3.23 | 3.23 | 1,351,143 |
| Sep 1, 2026 | 2.95 | 3.21 | 2.92 | 3.18 | 3.18 | 3,034,116 |
| Aug 31, 2026 | 3.15 | 3.26 | 3.04 | 3.22 | 3.22 | 1,543,036 |
| Aug 28, 2026 | 3.15 | 3.20 | 3.07 | 3.16 | 3.16 | 1,429,695 |
| Aug 27, 2026 | 3.11 | 3.27 | 3.09 | 3.18 | 3.18 | 1,278,031 |
| Aug 26, 2026 | 3.18 | 3.19 | 3.08 | 3.12 | 3.12 | 1,288,004 |
| Aug 25, 2026 | 3.06 | 3.21 | 3.01 | 3.19 | 3.19 | 1,757,379 |
| Aug 24, 2026 | 3.20 | 3.20 | 3.00 | 3.05 | 3.05 | 1,352,465 |
| Aug 21, 2026 | 3.22 | 3.25 | 3.12 | 3.20 | 3.20 | 1,279,035 |
| Aug 20, 2026 | 3.17 | 3.29 | 3.14 | 3.22 | 3.22 | 1,928,362 |
| Aug 19, 2026 | 2.95 | 3.20 | 2.92 | 3.19 | 3.19 | 2,194,148 |
| Aug 18, 2026 | 3.00 | 3.01 | 2.83 | 2.87 | 2.87 | 2,041,073 |
| Aug 17, 2026 | 3.01 | 3.08 | 2.97 | 3.05 | 3.05 | 1,387,825 |
| Aug 14, 2026 | 3.17 | 3.18 | 3.01 | 3.03 | 3.03 | 1,555,214 |
| Aug 13, 2026 | 3.24 | 3.28 | 3.15 | 3.17 | 3.17 | 1,619,917 |
| Aug 12, 2026 | 3.25 | 3.25 | 3.13 | 3.23 | 3.23 | 1,162,680 |
| Aug 11, 2026 | 3.23 | 3.27 | 3.15 | 3.22 | 3.22 | 1,485,433 |
| Aug 10, 2026 | 3.20 | 3.33 | 3.20 | 3.25 | 3.25 | 1,376,930 |
| Aug 7, 2026 | 3.22 | 3.29 | 3.18 | 3.26 | 3.26 | 1,440,869 |
| Aug 6, 2026 | 3.15 | 3.21 | 3.02 | 3.18 | 3.18 | 2,541,086 |
| Aug 5, 2026 | 3.12 | 3.26 | 3.04 | 3.15 | 3.15 | 3,714,646 |
| Aug 4, 2026 | 3.00 | 3.23 | 3.00 | 3.17 | 3.17 | 3,502,135 |
| Aug 3, 2026 | 2.92 | 3.12 | 2.74 | 3.02 | 3.02 | 7,816,892 |
| Jul 31, 2026 | 3.10 | 3.26 | 2.81 | 2.86 | 2.86 | 15,162,792 |
| Jul 30, 2026 | 5.07 | 5.38 | 5.03 | 5.37 | 5.37 | 2,156,224 |
| Jul 29, 2026 | 5.33 | 5.43 | 5.03 | 5.04 | 5.04 | 1,475,512 |
| Jul 28, 2026 | 5.49 | 5.53 | 5.23 | 5.32 | 5.32 | 1,164,945 |
| Jul 27, 2026 | 5.70 | 5.76 | 5.41 | 5.45 | 5.45 | 1,172,182 |
| Jul 24, 2026 | 5.71 | 5.76 | 5.58 | 5.61 | 5.61 | 867,630 |
| Jul 23, 2026 | 5.60 | 5.82 | 5.60 | 5.70 | 5.70 | 679,239 |
| Jul 22, 2026 | 5.88 | 5.89 | 5.58 | 5.66 | 5.66 | 627,408 |
| Jul 21, 2026 | 5.84 | 5.99 | 5.83 | 5.91 | 5.91 | 630,679 |
| Jul 20, 2026 | 6.12 | 6.19 | 5.83 | 5.92 | 5.92 | 687,178 |
| Jul 17, 2026 | 6.12 | 6.24 | 6.06 | 6.18 | 6.18 | 734,441 |
| Jul 16, 2026 | 6.28 | 6.43 | 6.10 | 6.19 | 6.19 | 965,983 |
| Jul 15, 2026 | 6.02 | 6.36 | 6.02 | 6.31 | 6.31 | 1,100,550 |
| Jul 14, 2026 | 5.80 | 6.08 | 5.79 | 6.04 | 6.04 | 896,466 |
| Jul 13, 2026 | 5.82 | 6.01 | 5.67 | 5.86 | 5.86 | 811,599 |
| Jul 10, 2026 | 6.12 | 6.12 | 5.73 | 5.83 | 5.83 | 856,979 |
| Jul 9, 2026 | 5.85 | 6.17 | 5.80 | 6.10 | 6.10 | 881,684 |
| Jul 8, 2026 | 5.81 | 5.89 | 5.71 | 5.87 | 5.87 | 1,430,201 |
| Jul 7, 2026 | 6.09 | 6.15 | 5.78 | 5.86 | 5.86 | 1,135,798 |
| Jul 6, 2026 | 5.98 | 6.25 | 5.74 | 6.03 | 6.03 | 1,063,765 |
| Jul 2, 2026 | 6.05 | 6.12 | 5.92 | 5.99 | 5.99 | 1,319,083 |
| Jul 1, 2026 | 5.73 | 6.00 | 5.72 | 6.00 | 6.00 | 1,626,483 |
| Jun 30, 2026 | 5.85 | 5.93 | 5.55 | 5.71 | 5.71 | 1,599,244 |
| Jun 29, 2026 | 5.84 | 6.04 | 5.73 | 5.85 | 5.85 | 1,929,249 |
| Jun 26, 2026 | 5.44 | 5.90 | 5.34 | 5.88 | 5.88 | 5,205,834 |
| Jun 25, 2026 | 5.26 | 5.50 | 5.21 | 5.43 | 5.43 | 2,062,498 |
| Jun 24, 2026 | 4.63 | 5.25 | 4.63 | 5.22 | 5.22 | 1,924,886 |
| Jun 23, 2026 | 4.41 | 4.71 | 4.39 | 4.63 | 4.63 | 1,271,865 |
| Jun 22, 2026 | 4.54 | 4.62 | 4.42 | 4.50 | 4.50 | 1,271,242 |
| Jun 18, 2026 | 4.40 | 4.58 | 4.40 | 4.54 | 4.54 | 2,436,337 |
| Jun 17, 2026 | 4.26 | 4.44 | 4.22 | 4.38 | 4.38 | 876,791 |
| Jun 16, 2026 | 4.31 | 4.40 | 4.21 | 4.25 | 4.25 | 1,273,711 |
| Jun 15, 2026 | 4.31 | 4.37 | 4.19 | 4.32 | 4.32 | 1,128,294 |
| Jun 12, 2026 | 4.63 | 4.67 | 4.21 | 4.33 | 4.33 | 1,192,460 |
| Jun 11, 2026 | 4.41 | 4.74 | 4.29 | 4.63 | 4.63 | 1,711,957 |
| Jun 10, 2026 | 4.54 | 4.79 | 4.40 | 4.43 | 4.43 | 1,444,921 |
| Jun 9, 2026 | 4.42 | 4.54 | 4.32 | 4.54 | 4.54 | 1,138,127 |
| Jun 8, 2026 | 4.59 | 4.64 | 4.36 | 4.39 | 4.39 | 973,905 |
| Jun 5, 2026 | 4.65 | 4.72 | 4.53 | 4.57 | 4.57 | 1,153,287 |
| Jun 4, 2026 | 4.40 | 4.78 | 4.40 | 4.69 | 4.69 | 1,638,780 |
| Jun 3, 2026 | 4.28 | 4.54 | 4.16 | 4.40 | 4.40 | 1,982,544 |
| Jun 2, 2026 | 4.22 | 4.45 | 4.12 | 4.31 | 4.31 | 2,380,739 |
| Jun 1, 2026 | 4.02 | 4.37 | 3.99 | 4.28 | 4.28 | 2,065,978 |
| May 29, 2026 | 4.21 | 4.25 | 3.92 | 3.97 | 3.97 | 6,042,298 |
| May 28, 2026 | 3.86 | 4.28 | 3.86 | 4.22 | 4.22 | 1,848,892 |
| May 27, 2026 | 3.88 | 3.95 | 3.83 | 3.93 | 3.93 | 866,012 |
| May 26, 2026 | 3.83 | 3.88 | 3.72 | 3.85 | 3.85 | 1,023,976 |
| May 22, 2026 | 3.88 | 3.95 | 3.77 | 3.82 | 3.82 | 1,034,572 |
| May 21, 2026 | 3.74 | 3.92 | 3.69 | 3.91 | 3.91 | 1,412,226 |
| May 20, 2026 | 3.55 | 3.82 | 3.54 | 3.81 | 3.81 | 2,099,047 |
| May 19, 2026 | 3.59 | 3.67 | 3.53 | 3.55 | 3.55 | 1,918,204 |
| May 18, 2026 | 3.58 | 3.79 | 3.56 | 3.65 | 3.65 | 2,201,387 |
| May 15, 2026 | 3.62 | 3.76 | 3.57 | 3.58 | 3.58 | 1,641,543 |
| May 14, 2026 | 3.73 | 3.77 | 3.62 | 3.62 | 3.62 | 1,697,477 |
| May 13, 2026 | 4.07 | 4.07 | 3.73 | 3.73 | 3.73 | 1,989,912 |
| May 12, 2026 | 4.20 | 4.24 | 4.07 | 4.07 | 4.07 | 1,175,139 |
| May 11, 2026 | 4.26 | 4.44 | 4.17 | 4.21 | 4.21 | 1,158,085 |
| May 8, 2026 | 4.13 | 4.38 | 4.00 | 4.29 | 4.29 | 1,983,486 |
| May 7, 2026 | 4.13 | 4.22 | 4.01 | 4.09 | 4.09 | 2,553,451 |
| May 6, 2026 | 4.13 | 4.42 | 3.75 | 4.11 | 4.11 | 7,460,239 |
| May 5, 2026 | 4.99 | 5.04 | 4.80 | 5.03 | 5.03 | 1,439,668 |
| May 4, 2026 | 4.78 | 4.97 | 4.78 | 4.94 | 4.94 | 1,135,102 |
| May 1, 2026 | 4.70 | 5.06 | 4.69 | 4.80 | 4.80 | 2,010,299 |
| Apr 30, 2026 | 4.55 | 4.83 | 4.55 | 4.75 | 4.75 | 1,010,270 |
| Apr 29, 2026 | 4.76 | 4.83 | 4.58 | 4.68 | 4.68 | 1,238,062 |
| Apr 28, 2026 | 4.84 | 4.92 | 4.78 | 4.84 | 4.84 | 901,342 |
| Apr 27, 2026 | 4.78 | 4.96 | 4.74 | 4.83 | 4.83 | 841,073 |
| Apr 24, 2026 | 4.77 | 4.85 | 4.71 | 4.78 | 4.78 | 735,811 |
| Apr 23, 2026 | 5.04 | 5.07 | 4.54 | 4.79 | 4.79 | 1,201,611 |
| Apr 22, 2026 | 4.99 | 5.11 | 4.99 | 5.08 | 5.08 | 717,126 |
| Apr 21, 2026 | 5.16 | 5.31 | 4.98 | 4.99 | 4.99 | 724,957 |
| Apr 20, 2026 | 5.04 | 5.22 | 4.91 | 5.14 | 5.14 | 760,822 |
| Apr 17, 2026 | 5.14 | 5.28 | 5.03 | 5.08 | 5.08 | 970,828 |
| Apr 16, 2026 | 5.28 | 5.30 | 4.97 | 5.00 | 5.00 | 1,359,616 |
| Apr 15, 2026 | 4.85 | 5.36 | 4.85 | 5.19 | 5.19 | 1,251,954 |
| Apr 14, 2026 | 4.60 | 4.93 | 4.60 | 4.91 | 4.91 | 1,028,385 |
| Apr 13, 2026 | 4.32 | 4.64 | 4.32 | 4.59 | 4.59 | 986,732 |
| Apr 10, 2026 | 4.45 | 4.62 | 4.31 | 4.35 | 4.35 | 1,061,397 |
| Apr 9, 2026 | 4.74 | 4.74 | 4.43 | 4.44 | 4.44 | 1,415,367 |
| Apr 8, 2026 | 4.85 | 4.99 | 4.71 | 4.77 | 4.77 | 955,691 |
| Apr 7, 2026 | 4.66 | 4.75 | 4.57 | 4.74 | 4.74 | 1,178,216 |
| Apr 6, 2026 | 4.75 | 4.86 | 4.67 | 4.67 | 4.67 | 609,569 |
| Apr 2, 2026 | 4.45 | 4.83 | 4.44 | 4.75 | 4.75 | 1,147,870 |
| Apr 1, 2026 | 4.53 | 4.70 | 4.51 | 4.59 | 4.59 | 855,187 |
| Mar 31, 2026 | 4.38 | 4.53 | 4.36 | 4.50 | 4.50 | 1,226,013 |
| Mar 30, 2026 | 4.28 | 4.38 | 4.20 | 4.36 | 4.36 | 1,368,950 |
| Mar 27, 2026 | 4.58 | 4.67 | 4.27 | 4.28 | 4.28 | 1,618,331 |
| Mar 26, 2026 | 4.62 | 4.81 | 4.58 | 4.62 | 4.62 | 930,727 |
| Mar 25, 2026 | 4.70 | 4.82 | 4.55 | 4.68 | 4.68 | 1,482,165 |
| Mar 24, 2026 | 4.64 | 4.79 | 4.55 | 4.61 | 4.61 | 1,774,055 |
| Mar 23, 2026 | 4.66 | 4.88 | 4.58 | 4.66 | 4.66 | 2,186,864 |
| Mar 20, 2026 | 4.77 | 4.86 | 4.54 | 4.58 | 4.58 | 17,564,301 |
| Mar 19, 2026 | 4.54 | 4.80 | 4.54 | 4.75 | 4.75 | 1,773,421 |
| Mar 18, 2026 | 4.68 | 5.05 | 4.38 | 4.64 | 4.64 | 2,197,974 |
| Mar 17, 2026 | 4.59 | 4.83 | 4.53 | 4.78 | 4.78 | 2,086,263 |
| Mar 16, 2026 | 4.66 | 4.79 | 4.53 | 4.59 | 4.59 | 1,731,881 |
| Mar 13, 2026 | 4.84 | 4.89 | 4.62 | 4.66 | 4.66 | 1,723,835 |
| Mar 12, 2026 | 4.91 | 5.11 | 4.75 | 4.85 | 4.85 | 2,231,395 |
| Mar 11, 2026 | 5.08 | 5.10 | 4.80 | 5.06 | 5.06 | 2,250,531 |
| Mar 10, 2026 | 5.18 | 5.47 | 5.00 | 5.12 | 5.12 | 2,566,825 |
| Mar 9, 2026 | 5.00 | 5.23 | 4.75 | 4.81 | 4.81 | 3,328,565 |
| Mar 6, 2026 | 4.96 | 5.17 | 4.84 | 5.15 | 5.15 | 1,563,891 |
| Mar 5, 2026 | 5.11 | 5.33 | 4.98 | 5.13 | 5.13 | 1,529,863 |
| Mar 4, 2026 | 5.30 | 5.49 | 5.26 | 5.28 | 5.28 | 1,419,731 |
| Mar 3, 2026 | 4.87 | 5.33 | 4.77 | 5.29 | 5.29 | 1,704,526 |
| Mar 2, 2026 | 5.06 | 5.17 | 4.67 | 5.01 | 5.01 | 2,174,426 |
| Feb 27, 2026 | 4.77 | 4.79 | 4.48 | 4.61 | 4.61 | 2,131,562 |
| Feb 26, 2026 | 4.82 | 5.02 | 4.71 | 4.86 | 4.86 | 1,509,374 |
| Feb 25, 2026 | 4.43 | 4.88 | 4.42 | 4.78 | 4.78 | 2,538,443 |
| Feb 24, 2026 | 5.57 | 5.71 | 4.38 | 4.43 | 4.43 | 5,267,755 |
| Feb 23, 2026 | 4.27 | 4.40 | 4.10 | 4.38 | 4.38 | 2,681,182 |
| Feb 20, 2026 | 4.32 | 4.38 | 4.21 | 4.29 | 4.29 | 1,161,662 |
| Feb 19, 2026 | 4.34 | 4.41 | 4.26 | 4.38 | 4.38 | 835,114 |
| Feb 18, 2026 | 4.50 | 4.57 | 4.32 | 4.37 | 4.37 | 819,876 |
| Feb 17, 2026 | 4.49 | 4.61 | 4.34 | 4.50 | 4.50 | 917,355 |
| Feb 13, 2026 | 4.52 | 4.71 | 4.46 | 4.49 | 4.49 | 1,035,608 |
| Feb 12, 2026 | 4.84 | 4.93 | 4.42 | 4.53 | 4.53 | 1,079,121 |
| Feb 11, 2026 | 5.09 | 5.15 | 4.83 | 4.85 | 4.85 | 1,438,599 |
| Feb 10, 2026 | 5.10 | 5.29 | 5.05 | 5.08 | 5.08 | 888,515 |
| Feb 9, 2026 | 5.11 | 5.12 | 5.03 | 5.07 | 5.07 | 992,828 |
| Feb 6, 2026 | 5.12 | 5.28 | 5.01 | 5.12 | 5.12 | 976,916 |
| Feb 5, 2026 | 5.23 | 5.37 | 5.03 | 5.10 | 5.10 | 1,236,490 |
| Feb 4, 2026 | 5.38 | 5.43 | 5.14 | 5.30 | 5.30 | 1,025,441 |
| Feb 3, 2026 | 5.46 | 5.70 | 5.32 | 5.34 | 5.34 | 1,021,470 |
| Feb 2, 2026 | 5.51 | 5.68 | 5.42 | 5.47 | 5.47 | 794,497 |
| Jan 30, 2026 | 5.49 | 5.66 | 5.41 | 5.62 | 5.62 | 916,649 |
| Jan 29, 2026 | 5.73 | 5.75 | 5.53 | 5.54 | 5.54 | 668,071 |
| Jan 28, 2026 | 5.95 | 5.95 | 5.68 | 5.72 | 5.72 | 668,879 |
| Jan 27, 2026 | 5.79 | 5.93 | 5.62 | 5.92 | 5.92 | 586,329 |
| Jan 26, 2026 | 5.85 | 5.97 | 5.77 | 5.81 | 5.81 | 738,630 |
| Jan 23, 2026 | 6.01 | 6.02 | 5.74 | 5.87 | 5.87 | 806,155 |
| Jan 22, 2026 | 5.86 | 6.15 | 5.83 | 6.06 | 6.06 | 1,342,291 |
| Jan 21, 2026 | 5.68 | 5.89 | 5.62 | 5.84 | 5.84 | 1,005,961 |
| Jan 20, 2026 | 6.00 | 6.02 | 5.46 | 5.68 | 5.68 | 1,337,848 |
| Jan 16, 2026 | 6.04 | 6.11 | 5.88 | 5.92 | 5.92 | 1,050,190 |
| Jan 15, 2026 | 6.08 | 6.20 | 5.81 | 6.04 | 6.04 | 1,150,292 |
| Jan 14, 2026 | 6.16 | 6.17 | 5.90 | 6.11 | 6.11 | 977,698 |
| Jan 13, 2026 | 6.60 | 6.70 | 6.12 | 6.20 | 6.20 | 947,972 |
| Jan 12, 2026 | 6.62 | 7.15 | 6.48 | 6.57 | 6.57 | 950,824 |
| Jan 9, 2026 | 6.64 | 6.71 | 6.40 | 6.58 | 6.58 | 849,834 |
| Jan 8, 2026 | 6.44 | 6.66 | 6.44 | 6.56 | 6.56 | 832,807 |
| Jan 7, 2026 | 6.52 | 6.85 | 6.50 | 6.63 | 6.63 | 839,082 |
| Jan 6, 2026 | 6.13 | 6.55 | 6.10 | 6.52 | 6.52 | 1,175,304 |
| Jan 5, 2026 | 6.15 | 6.22 | 6.08 | 6.14 | 6.14 | 812,301 |
| Jan 2, 2026 | 6.17 | 6.31 | 6.10 | 6.14 | 6.14 | 707,256 |
| Dec 31, 2025 | 6.14 | 6.20 | 6.10 | 6.15 | 6.15 | 703,987 |
| Dec 30, 2025 | 6.30 | 6.30 | 6.15 | 6.17 | 6.17 | 484,796 |
| Dec 29, 2025 | 6.57 | 6.57 | 6.29 | 6.31 | 6.31 | 663,304 |
| Dec 26, 2025 | 6.53 | 6.62 | 6.39 | 6.48 | 6.48 | 936,497 |
| Dec 24, 2025 | 6.51 | 6.56 | 6.38 | 6.55 | 6.55 | 424,709 |
| Dec 23, 2025 | 6.73 | 6.77 | 6.54 | 6.56 | 6.56 | 498,791 |
| Dec 22, 2025 | 6.58 | 6.89 | 6.51 | 6.76 | 6.76 | 1,001,833 |
| Dec 19, 2025 | 6.70 | 6.74 | 6.53 | 6.55 | 6.55 | 3,259,616 |
| Dec 18, 2025 | 7.03 | 7.20 | 6.62 | 6.70 | 6.70 | 759,656 |
| Dec 17, 2025 | 6.92 | 7.12 | 6.80 | 6.95 | 6.95 | 691,806 |
| Dec 16, 2025 | 6.92 | 7.05 | 6.88 | 6.88 | 6.88 | 780,895 |
| Dec 15, 2025 | 7.29 | 7.32 | 6.91 | 6.99 | 6.99 | 1,145,521 |
| Dec 12, 2025 | 7.30 | 7.39 | 7.20 | 7.21 | 7.21 | 1,078,945 |
| Dec 11, 2025 | 7.21 | 7.43 | 7.14 | 7.30 | 7.30 | 757,441 |
| Dec 10, 2025 | 7.37 | 7.37 | 7.17 | 7.23 | 7.23 | 727,043 |
| Dec 9, 2025 | 7.06 | 7.37 | 6.99 | 7.35 | 7.35 | 1,128,170 |
| Dec 8, 2025 | 7.18 | 7.25 | 7.07 | 7.07 | 7.07 | 891,242 |
| Dec 5, 2025 | 7.30 | 7.35 | 7.06 | 7.09 | 7.09 | 557,338 |
| Dec 4, 2025 | 7.31 | 7.38 | 7.15 | 7.33 | 7.33 | 695,097 |
| Dec 3, 2025 | 7.06 | 7.35 | 7.02 | 7.33 | 7.33 | 913,024 |
| Dec 2, 2025 | 7.06 | 7.15 | 6.92 | 7.02 | 7.02 | 873,508 |
| Dec 1, 2025 | 7.54 | 7.54 | 7.01 | 7.06 | 7.06 | 1,236,613 |
| Nov 28, 2025 | 7.63 | 7.72 | 7.50 | 7.63 | 7.63 | 427,291 |
| Nov 26, 2025 | 7.89 | 7.89 | 7.57 | 7.60 | 7.60 | 2,515,498 |
| Nov 25, 2025 | 7.83 | 8.09 | 7.71 | 7.91 | 7.91 | 1,078,169 |
| Nov 24, 2025 | 7.38 | 7.79 | 7.32 | 7.73 | 7.73 | 1,311,434 |
| Nov 21, 2025 | 6.91 | 7.49 | 6.82 | 7.38 | 7.38 | 1,449,283 |
| Nov 20, 2025 | 6.59 | 7.24 | 6.55 | 6.90 | 6.90 | 1,376,832 |
| Nov 19, 2025 | 6.60 | 6.88 | 6.43 | 6.44 | 6.44 | 1,202,104 |
| Nov 18, 2025 | 6.61 | 6.87 | 6.61 | 6.63 | 6.63 | 1,195,454 |
| Nov 17, 2025 | 6.60 | 6.89 | 6.49 | 6.66 | 6.66 | 1,231,073 |
| Nov 14, 2025 | 6.25 | 6.83 | 6.25 | 6.71 | 6.71 | 1,137,334 |
| Nov 13, 2025 | 6.45 | 6.67 | 6.26 | 6.35 | 6.35 | 1,643,483 |
| Nov 12, 2025 | 6.69 | 6.71 | 6.49 | 6.54 | 6.54 | 1,229,106 |
| Nov 11, 2025 | 6.45 | 6.71 | 6.39 | 6.68 | 6.68 | 967,915 |
| Nov 10, 2025 | 6.40 | 6.64 | 6.37 | 6.48 | 6.48 | 1,146,947 |
| Nov 7, 2025 | 6.29 | 6.37 | 6.10 | 6.30 | 6.30 | 1,047,538 |
| Nov 6, 2025 | 6.52 | 6.60 | 6.21 | 6.33 | 6.33 | 1,318,914 |
| Nov 5, 2025 | 6.42 | 6.82 | 6.40 | 6.58 | 6.58 | 1,251,948 |
| Nov 4, 2025 | 7.42 | 7.59 | 6.20 | 6.46 | 6.46 | 2,698,381 |
| Nov 3, 2025 | 8.05 | 8.38 | 7.77 | 8.18 | 8.18 | 1,870,582 |
| Oct 31, 2025 | 7.93 | 8.11 | 7.80 | 8.04 | 8.04 | 903,969 |
| Oct 30, 2025 | 8.00 | 8.10 | 7.81 | 7.95 | 7.95 | 929,182 |
| Oct 29, 2025 | 8.10 | 8.18 | 7.76 | 7.91 | 7.91 | 766,532 |
| Oct 28, 2025 | 8.05 | 8.17 | 7.97 | 8.13 | 8.13 | 679,832 |
| Oct 27, 2025 | 8.27 | 8.50 | 8.01 | 8.10 | 8.10 | 1,151,285 |
| Oct 24, 2025 | 8.07 | 8.16 | 7.92 | 8.15 | 8.15 | 767,097 |
| Oct 23, 2025 | 7.84 | 8.05 | 7.67 | 8.05 | 8.05 | 760,021 |
| Oct 22, 2025 | 8.15 | 8.24 | 7.83 | 7.86 | 7.86 | 731,456 |
| Oct 21, 2025 | 7.93 | 8.24 | 7.84 | 8.06 | 8.06 | 792,685 |
| Oct 20, 2025 | 7.91 | 8.18 | 7.84 | 7.90 | 7.90 | 1,020,534 |
| Oct 17, 2025 | 8.00 | 8.15 | 7.76 | 7.80 | 7.80 | 799,406 |
| Oct 16, 2025 | 8.18 | 8.59 | 8.01 | 8.08 | 8.08 | 1,079,834 |
| Oct 15, 2025 | 7.84 | 8.13 | 7.77 | 8.10 | 8.10 | 930,781 |
| Oct 14, 2025 | 7.83 | 8.07 | 7.62 | 7.80 | 7.80 | 963,794 |
| Oct 13, 2025 | 7.59 | 7.95 | 7.57 | 7.84 | 7.84 | 890,665 |
| Oct 10, 2025 | 7.79 | 7.79 | 7.34 | 7.50 | 7.50 | 1,040,835 |
| Oct 9, 2025 | 7.61 | 7.96 | 7.55 | 7.74 | 7.74 | 787,846 |
| Oct 8, 2025 | 7.64 | 8.04 | 7.54 | 7.64 | 7.64 | 929,626 |
| Oct 7, 2025 | 8.04 | 8.10 | 7.52 | 7.53 | 7.53 | 958,713 |
| Oct 6, 2025 | 8.00 | 8.24 | 7.92 | 7.99 | 7.99 | 1,147,697 |
| Oct 3, 2025 | 7.58 | 8.12 | 7.58 | 8.06 | 8.06 | 1,335,425 |
| Oct 2, 2025 | 7.76 | 7.84 | 7.41 | 7.56 | 7.56 | 870,766 |
| Oct 1, 2025 | 7.29 | 7.78 | 7.23 | 7.73 | 7.73 | 988,304 |
| Sep 30, 2025 | 7.17 | 7.29 | 7.04 | 7.23 | 7.23 | 1,199,045 |
| Sep 29, 2025 | 7.70 | 7.71 | 7.13 | 7.24 | 7.24 | 1,196,269 |
| Sep 26, 2025 | 7.79 | 7.83 | 7.57 | 7.70 | 7.70 | 1,354,095 |
| Sep 25, 2025 | 7.68 | 7.97 | 7.50 | 7.76 | 7.76 | 1,485,370 |
| Sep 24, 2025 | 7.66 | 7.77 | 7.47 | 7.72 | 7.72 | 1,274,899 |
| Sep 23, 2025 | 7.91 | 8.04 | 7.69 | 7.70 | 7.70 | 1,829,649 |
| Sep 22, 2025 | 7.75 | 8.04 | 7.67 | 7.84 | 7.84 | 1,644,790 |
Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.
The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.
Explore the Quiver APIWe estimate that -- received a compensation of -- in --, making them the highest paid executive at MYGN, per a recent SEC DEF 14A filing. We estimate that the median employee at MYRIAD GENETICS INC is paid $97,407.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|